A.R.T. Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-27,591
| Closed | -$87K | – | 1919 |
|
|
2019
Q2 | $87K | Buy |
+27,591
| New | +$87K | ﹤0.01% | 1212 |
|
|
2019
Q1 | – | Sell |
-36,391
| Closed | -$106K | – | 1813 |
|
|
2018
Q4 | $106K | Sell |
36,391
-98,319
| -73% | -$286K | 0.01% | 1158 |
|
|
2018
Q3 | $354K | Buy |
+134,710
| New | +$354K | 0.02% | 980 |
|
|
2018
Q2 | – | Sell |
-150,099
| Closed | -$441K | – | 1998 |
|
|
2018
Q1 | $441K | Buy |
+150,099
| New | +$441K | 0.02% | 1007 |
|
|
2017
Q3 | – | Sell |
-39,109
| Closed | -$96K | – | 1917 |
|
|
2017
Q2 | $96K | Sell |
39,109
-331,891
| -89% | -$815K | 0.01% | 1258 |
|
|
2017
Q1 | $842K | Buy |
371,000
+208,100
| +128% | +$472K | 0.04% | 620 |
|
|
2016
Q4 | $345K | Buy |
+162,900
| New | +$345K | 0.02% | 893 |
|
|
2016
Q3 | – | Sell |
-432,031
| Closed | -$1.36M | – | 1548 |
|
|
2016
Q2 | $1.36M | Sell |
432,031
-379,977
| -47% | -$1.19M | 0.07% | 431 |
|
|
2016
Q1 | $2.7M | Buy |
812,008
+204,700
| +34% | +$681K | 0.12% | 236 |
|
|
2015
Q4 | $2.15M | Buy |
607,308
+507,647
| +509% | +$1.8M | 0.1% | 270 |
|
|
2015
Q3 | $501K | Sell |
99,661
-253,011
| -72% | -$1.27M | 0.02% | 876 |
|
|
2015
Q2 | $2.27M | Buy |
352,672
+248,579
| +239% | +$1.6M | 0.08% | 397 |
|
|
2015
Q1 | $732K | Sell |
104,093
-156,169
| -60% | -$1.1M | 0.03% | 774 |
|
|
2014
Q4 | $2.01M | Buy |
260,262
+89,383
| +52% | +$689K | 0.07% | 395 |
|
|
2014
Q3 | $1.28M | Buy |
+170,879
| New | +$1.28M | 0.06% | 435 |
|
|
2013
Q4 | – | Sell |
-181,769
| Closed | -$1.45M | – | 1785 |
|
|
2013
Q3 | $1.45M | Buy |
+181,769
| New | +$1.45M | 0.08% | 376 |
|